Title:
被検細胞の細胞特性を評価するための遺伝子マーカー、方法、レポーターベクター、プライマーセットおよびアッセイキット、並びに細胞特性評価装置
Document Type and Number:
Japanese Patent JP6793451
Kind Code:
B2
Abstract:
PROBLEM TO BE SOLVED: To provide means for examining the cellular property of test cells to select the therapeutic method of malignant tumor more appropriately.SOLUTION: There is provided a gene marker for examining the cellular property of test cells. There is provided a mRNA, peptide or protein of nicotinamide phosphoribosyl-group transferase (NAMPT) gene, or a gene marker that is a polynucleotide comprising the promoter sequence of NAMPT gene. The gene marker can be used to examine the cellular property relating to metastatic property of tumor cells of the subject, because NAMPT gene is an indicator gene having high correlation with the metastatic property of tumor cells, overexpressed in tumors that have strong metastatic ability.SELECTED DRAWING: Figure 1
Inventors:
Eiichi Akahoshi
Mitsuko Ishihara
Mitsuko Ishihara
Application Number:
JP2015223967A
Publication Date:
December 02, 2020
Filing Date:
November 16, 2015
Export Citation:
Assignee:
Canon Medical Systems Corporation
International Classes:
C12N15/12; C12M1/34; C12Q1/06; C12Q1/6851; G01N33/50; G01N33/574; G01N33/68
Domestic Patent References:
JP2013042721A | ||||
JP2008532519A |
Foreign References:
WO2012075042A1 | ||||
WO2007139201A1 | ||||
WO2010125566A1 | ||||
US20140162889 | ||||
WO2005021788A1 |
Other References:
Genes & Cancer, 2013, Vol.4, No.11-12, p.447-456
Scientific Reports, 2014, Vol.4, No. 6107, p.1-8
Scientific Reports, 2014, Vol.4, No. 6107, p.1-8
Attorney, Agent or Firm:
Suzue International Patent Office